Literature DB >> 32947580

Psychotic, Mood, and Anxiety Disorders and Venous Thromboembolism: A Systematic Review and Meta-Analysis.

Célia Kowal1, Hugo Peyre, Ali Amad, Antoine Pelissolo, Marion Leboyer, Franck Schürhoff, Baptiste Pignon.   

Abstract

OBJECTIVE: Several studies have shown that psychiatric disorders can be associated with venous thromboembolism (VTE) risk, that is, pulmonary embolism (PE) and/or deep vein thrombosis (DVT). In this study, we provide a systematic review and meta-analyses of the studies addressing this issue.
METHODS: All studies addressing the risk of VTE phenomena (whole VTE, PE, DVT, fatal VTE) in individuals with psychotic, mood, and anxiety disorders published between 1998 and 2019 were reviewed and included in the meta-analyses. Main characteristics of the studies and data concerning VTE risk were extracted. The methodological qualities of the studies were also analyzed. A random-effects meta-analysis model was used. A meta-analysis was conducted separately for each disorder, as well as separately for unadjusted and adjusted studies. Meta-analyses were repeated considering only good-quality studies. Heterogeneity was assessed.
RESULTS: Sixteen studies were reviewed and 15 included in the meta-analyses. Psychotic and bipolar disorders were significantly associated with VTE risk (VTE, DVT, PE, and fatal VTE for psychotic disorder: odds ratios [ORs] between 1.29 and 2.20; VTE, DVT, and PE for bipolar disorder: ORs between 1.22 and 2.14). Depression and anxiety disorders were associated with VTE risk only in adjusted analyses (DVT and PE for depression: ORs = 1.29; VTE and PE for anxiety disorders: ORs between 1.14 and 1.49).
CONCLUSIONS: The risk of VTE among individuals with psychiatric disorders may be explained by hypercoagulability and stasis, with both being related to, and independent of, treatment adverse effects. VTE risk should be taken into consideration in the treatment for people with psychiatric disorders.

Entities:  

Year:  2020        PMID: 32947580     DOI: 10.1097/PSY.0000000000000863

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  6 in total

Review 1.  Application of pulmonary rehabilitation in patients with pulmonary embolism (Review).

Authors:  Aiping Yu; Weiping Ding; Wanmi Lin; Juan Cai; Weina Huang
Journal:  Exp Ther Med       Date:  2021-12-01       Impact factor: 2.447

2.  Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort.

Authors:  Marianne Foiselle; Susana Barbosa; Ophélia Godin; Ching-Lien Wu; Wahid Boukouaci; Myrtille Andre; Bruno Aouizerate; Fabrice Berna; Caroline Barau; Delphine Capdevielle; Pierre Vidailhet; Isabelle Chereau; Laetitia Davidovic; Jean-Michel Dorey; Caroline Dubertret; Julien Dubreucq; Catherine Faget; Guillaume Fond; Sylvain Leigner; Pierre-Michel Llorca; Jasmina Mallet; David Misdrahi; Emanuela Martinuzzi; Christine Passerieux; Romain Rey; Baptiste Pignon; Mathieu Urbach; Franck Schürhoff; Nicolas Glaichenhaus; Marion Leboyer; Ryad Tamouza
Journal:  Brain Behav Immun Health       Date:  2022-03-29

3.  Pulmonary embolism and deep vein thrombosis-comorbidities and temporary provoking factors in a register-based study of 1.48 million people.

Authors:  Katarina Glise Sandblad; Annika Rosengren; Jan Sörbo; Sverker Jern; Per-Olof Hansson
Journal:  Res Pract Thromb Haemost       Date:  2022-06-03

4.  Risk factor for venous thromboembolism after high tibial osteotomy -analysis of patient demographics, medical comorbidities, operative valuables, and clinical results.

Authors:  Mitsuaki Kubota; Youngji Kim; Tetsuya Inui; Taisuke Sato; Haruka Kaneko; Muneaki Ishijima
Journal:  J Orthop       Date:  2021-05-04

5.  Depressive Disorders Lead to Increased Complications After Geriatric Hip Fractures.

Authors:  Matthew S Broggi; Philip O Oladeji; Syed Tahmid; Roberto Hernandez-Irizarry; Jerad Allen
Journal:  Geriatr Orthop Surg Rehabil       Date:  2021-05-25

Review 6.  Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation.

Authors:  Md Mominur Rahman; Md Rezaul Islam; Sadia Afsana Mim; Nasrin Sultana; Dinesh Kumar Chellappan; Kamal Dua; Mohammad Amjad Kamal; Rohit Sharma; Talha Bin Emran
Journal:  Oxid Med Cell Longev       Date:  2022-09-21       Impact factor: 7.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.